- Report
- May 2025
- 120 Pages
Global
From €4209EUR$4,750USD£3,612GBP
- Report
- May 2023
- 147 Pages
Global
From €4386EUR$4,949USD£3,763GBP
- Report
- July 2024
- 160 Pages
Global
From €2215EUR$2,500USD£1,901GBP
- Report
- February 2026
- 213 Pages
Canada
From €4298EUR$4,850USD£3,688GBP
- Report
- February 2026
- 222 Pages
China
From €4298EUR$4,850USD£3,688GBP
- Report
- February 2026
- 214 Pages
Germany
From €4298EUR$4,850USD£3,688GBP
- Report
- February 2026
- 215 Pages
India
From €4298EUR$4,850USD£3,688GBP
- Report
- March 2025
- 150 Pages
Global
From €4298EUR$4,850USD£3,688GBP
- Report
- February 2026
- 218 Pages
Japan
From €4298EUR$4,850USD£3,688GBP
- Report
- March 2025
- 150 Pages
Global
From €4298EUR$4,850USD£3,688GBP
- Report
- February 2025
- 150 Pages
Global
From €4298EUR$4,850USD£3,688GBP
- Report
- June 2025
- 270 Pages
Global
From €4426EUR$4,995USD£3,798GBP
- Report
- May 2025
- 104 Pages
Global
From €3500EUR$4,231USD£3,108GBP
- Report
- June 2025
- 160 Pages
Global
From €4298EUR$4,850USD£3,688GBP
- Report
- January 2026
- 75 Pages
From €3057EUR$3,450USD£2,623GBP
- Report
- April 2025
- 220 Pages
Global
From €3988EUR$4,500USD£3,422GBP
- Report
- August 2024
- 112 Pages
Global
From €3988EUR$4,500USD£3,422GBP
- Report
- August 2023
- 180 Pages
Global
From €3323EUR$3,750USD£2,852GBP
- Training
- 35 Hours
Global
€3607EUR$4,070USD£3,095GBP
- Report
- August 2023
- 98 Pages
Global
From €3500EUR$4,231USD£3,108GBP

The Drug Screening market is an important part of the Drug Discovery process. It involves the use of high-throughput screening (HTS) technologies to identify potential drug candidates from a large library of compounds. HTS technologies allow for the rapid screening of thousands of compounds in a short period of time, making it an efficient and cost-effective way to identify potential drug candidates.
The Drug Screening market is highly competitive, with a number of companies offering a variety of HTS technologies. Companies in the market include Agilent Technologies, Bio-Rad Laboratories, PerkinElmer, Thermo Fisher Scientific, and Promega Corporation. These companies provide a range of products and services, including automated liquid handling systems, cell-based assays, and high-content imaging systems. Show Less Read more